SG/PUT/NOVO-NORDISK B/800/0.1/21.03.25 Share Price

Warrant

DE000SW7ZJK3

Market Closed - Bid/Ask 19:17:04 03/07/2024 BST
0.61 EUR +15.09% Intraday chart for SG/PUT/NOVO-NORDISK B/800/0.1/21.03.25
Current month+1.92%
1 month-31.17%
Date Price Change
03/07/24 0.61 +15.09%
02/07/24 0.53 +10.42%
01/07/24 0.48 -7.69%
28/06/24 0.52 +1.96%
27/06/24 0.51 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 07:17 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ZJK
ISINDE000SW7ZJK3
Date issued 20/03/2024
Strike 800 kr
Maturity 21/03/2025 (261 Days)
Parity 10 : 1
Emission price 1.12
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.29
Lowest since issue 0.44
Delta0x
Omega 0.000000
Premium0x
Gearing21.07x
Moneyness 0.8269
Difference Strike -167.5 kr
Difference Strike %-20.94%
Spread 0.03
Spread %4.76%
Intrinsic value 0.000000
Present value 0.6150

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus